CD8A and neoplasm: Groh and colleagues made an early observation in patients with a range of human epithelial tumours, including breast, lung, ovarian, colon and melanoma, that NKG2D receptor expression was significantly decreased on CD8+ tumour-infiltrating lymphocytes (TILs), NK cells and γδ T cells in patients with tumours positive for MIC [118].